An Unexpected New Lung Function Has Been Found - They Make Blood
Things just got complicated.
Researchers have discovered that the lungs play a far more complex role in mammalian bodies than we thought, with new evidence revealing that they don't just facilitate respiration - they also play a key role in blood production.
In experiments involving mice, the team found that they produce more than 10 million platelets (tiny blood cells) per hour, equating to the majority of platelets in the animals' circulation. This goes against the decades-long assumption that bone marrow produces all of our blood components.
////////////////////////// LOADER //////////////////////////////////// //////////////////////////////////////////////////////////////////////
Prescribing Information and Medication Guide
Important Safety Information
What is the most important information I should know about Nplate®?
Nplate® can cause serious side effects:
- Worsening of a precancerous blood condition to a blood cancer (leukemia):
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS) or for any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
- Higher risk for blood clots:
- You may have a higher risk of getting a blood clot if your platelet count becomes high during treatment with Nplate®. You may have severe complications or die from some forms of blood clots, such as clots that spread to the lungs or that cause heart attacks or strokes. Your healthcare provider will check your blood platelet counts and change your dose or stop Nplate® if your platelet counts get high.
- If you have a chronic liver disease, you may get blood clots in the veins of your liver. This may affect your liver function.
- Loss of response: If you do not experience results from Nplate®, your immune system may have created a response that is counteractive to Nplate®. Your healthcare provider will monitor your platelet counts and test your blood regularly to determine if this is an issue.
- Blood test monitoring: Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to have blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
- What are the possible side effects of Nplate®?
- Nplate® may cause serious side effects. See "What is the most important information I should know about Nplate®?"
- The most common side effects of Nplate® are:
- Joint pain
- Trouble sleeping
- Muscle tenderness or weakness
- Pain in arms and legs
- Stomach (Abdomen) pain
- Shoulder pain
- Tingling or numbness in hands and feet
- People who take Nplate® may have an increased risk of developing new or worsening changes in the bone marrow called “increased reticulin”. These changes may improve if you stop taking Nplate®. Your healthcare provider may need to check your bone marrow for this problem during treatment with Nplate®.
- These are not all the possible side effects of Nplate®.
- If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see Prescribing Information and Medication Guide for more information about Nplate®.
Nplate® is a man-made protein medicine used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP), when certain other medicines, or surgery to remove your spleen, have not worked well enough.
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS) or low platelet count caused by any condition other than chronic (lasting a long time) immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 18.
Researchers from the University of California, San Francisco also discovered a previously unknown pool of blood stem cells that makes this happen inside the lung tissue - cells that were incorrectly assumed to mainly reside in bone marrow.
"This finding definitely suggests a more sophisticated view of the lungs - that they're not just for respiration, but also a key partner in formation of crucial aspects of the blood," says one of the researchers, Mark R. Looney.
"What we've observed here in mice strongly suggests the lung may play a key role in blood formation in humans as well."
While the lungs have been known to produce a limited amount of platelets - platelet-forming cells called megakaryocytes have been identified in the lungs before - scientists have long assumed that most of the cells responsible for blood production are kept inside the bone marrow.
Here, a process called haematopoiesis was thought to churn out oxygen-laden red blood cells, infection-fighting white blood cells, and platelets - blood components required for the clotting that halts bleeding.
But scientists have now watched megakaryocytes functioning from within the lung tissue to produce not a few, but most of the body's platelets.
Toenail Fungus Gone In 3 Days (Just Do This Tonight Before Bed)
This breakthrough treatment is leaving doctors in awe.
Watch The Video
So how did we miss such a crucial biological process this whole time?
The discovery was made possible by a new type of technology based on two-photon intravital imaging - a similar technique to one used by a separate team this week to discover a previously unidentified function of the brain's cerebellum.
The process involves inserting a substance called green fluorescent protein (GFP) into the mouse genome - a protein that's naturally produced by bioluminescent animals such as jellyfish, and is harmless to living cells.
The mouse platelets started to emit bright green fluorescence as they circulated around the body in real time, allowing the team to trace their paths like never before.
They noticed a surprisingly large population of platelet-producing megakaryocytes inside the lung tissue, which initially didn't make much sense, seeing as they're usually associated with bone marrow.
"When we discovered this massive population of megakaryocytes that appeared to be living in the lung, we realised we had to follow this up," says one of the team, Emma Lefrançais.
They found that this huge supply of megakaryocytes is actually producing more than 10 million platelets per hour in the lungs of mice, which means at least half of the body's total platelet production is occurring in the lungs.
Here's what it looks like:
An error occurred.
Further experiments also revealed vast amounts of previously hidden blood stem cells and megakaryocyte progenitor cells (cells that give rise to megakaryocyte and red blood cells) sitting just outside the lung tissue - about 1 million per mouse lung.
When the researchers traced the entire 'life cycle' of the megakaryocytes, they found that they likely originate in the bone marrow, then make their way to the lungs, where they start platelet production.
"It's fascinating that megakaryocytes travel all the way from the bone marrow to the lungs to produce platelets," says one of the team, Guadalupe Ortiz-Muñoz.
"It's possible that the lung is an ideal bioreactor for platelet production because of the mechanical force of the blood, or perhaps because of some molecular signalling we don't yet know about."
The researchers wanted to investigate if their discovery could have an effect on how we treat disorders such as lung inflammation, bleeding, and transplantation in the future, by transplanting lungs with fluorescent megakaryocyte progenitor cells into mice with low platelet counts.
The transplants produced a massive burst of platelets that quickly restored the depleted platelet counts to normal levels, and the effect lasted for several months.
Another experiment tested what would happen if the bone marrow wasn't playing a role in blood production.
The team implanted lungs with fluorescent megakaryocyte progenitor cells into mice that had been engineered to have no blood stem cells in their bone marrow.
As Michael Irving reports for New Atlas, they watched as the fluorescent cells from the transplanted lungs made their way to the bone marrow, where they not only helped to produce platelets, but also other key blood components, such as neutrophils, B cells and T cells.
The findings will need to be replicated in humans before we can know for sure that the same process is occurring within our own bodies, but the study makes a strong case for this hidden function in what could be one of our most underrated organs.
It will likely also prompt scientists to investigate further how the bone marrow and lungs work together to produce our blood supply.
"It has been known for decades that the lung can be a site of platelet production, but this study amplifies this idea by demonstrating that the [mouse] lung is a major participant in the process," Traci Mondoro from the US National Heart, Lung, and Blood Institute, who was not involved in the study, said in a press statement.
"Looney and his team have disrupted some traditional ideas about the pulmonary role in platelet-related hematopoiesis, paving the way for further scientific exploration of this integrated biology."
The research has been published in Nature.